call Toll Free (US/Canada) : +1 866 658 6826 | call +1 425 320 4776 | call (UK) : +44 1865 60 0662 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Global Active Pharmaceutical Ingredients Market Bwc19271
Inquire Before Buying Request for Sample

Global Active Pharmaceutical Ingredients Market Bwc19271

Home Healthcare And Pharmaceutical Global Active Pharmaceutical Ingredients Market Bwc19271

SPECIAL OFFER : 25% Super Discount For All !

Active Pharmaceutical Ingredients (API) Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By API (Synthetic API, Biological API); By Manufacturer (Captive Manufacturers, Merchant Manufacturers); By Type of Drug (Branded/Innovator Drugs, Generic Drugs); By Therapeutic Area (Cardiovascular System, Central Nervous System (CNS), Respiratory System, Oncology, Gastrointestinal System, Others); By Potency (Traditional API, HPAPI); Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)

  • Published Date: July 2023
  • Report ID: BWC19271
  • Available Format: PDF
  • Page: 400
  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3.  Global Active Pharmaceutical Ingredients (API) Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing demand for generic drugs
        2. Rising prevalence of chronic diseases
        3. Growing focus on research and development of new APIs
      2. Restrains
        1. Stringent regulatory requirements
        2. Price volatility
      3. Opportunities
        1. Growing demand from emerging markets
        2. Development of new technologies
      4. Challenges
        1. Regulatory challenges
        2. Competition from generics
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4.  Global Active Pharmaceutical Ingredients (API) Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share and Forecast
      1. By API
        1. Synthetic API
        2. Biological API
      2. By Manufacturer
        1. Captive Manufacturers
        2. Merchant Manufacturers
      3. By Type of Drug
        1. Branded/Innovator Drugs
        2. Generic Drugs
      4. By Therapeutic Area
        1. Cardiovascular System
        2. Central Nervous System (CNS)
        3. Respiratory System
        4. Oncology
        5. Gastrointestinal System
        6. Others
      5. By Potency
        1. Traditional API
        2. HPAPI
      6. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Active Pharmaceutical Ingredients (API) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
      6. By Country
        1. United States
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        2. Canada
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
  6. Europe Active Pharmaceutical Ingredients (API) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
      6. By Country
        1. Germany
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        2. United Kingdom
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        3. Italy
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        4. France
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        5. Spain
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        6. Belgium
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        7. Russia
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        8. The Netherlands
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        9. Rest of Europe
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
  7. Asia-Pacific Active Pharmaceutical Ingredients (API) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
      6. By Country
        1. China
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        2. India
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        3. Japan
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        4. South Korea
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        5. Australia & New Zealand
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        6. Indonesia
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        7. Malaysia
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        8. Singapore
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        9. Vietnam
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        10. Rest of APAC
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
  8. Latin America Active Pharmaceutical Ingredients (API) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
        1. By API
        2. By Manufacturer
        3. By Type of Drug
        4. By Therapeutic Area
        5. By Potency
      2. By Country
        1. Brazil
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        2. Mexico
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        3. Argentina
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        4. Peru
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        5. Rest of LATAM
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
  9. Middle East & Africa Active Pharmaceutical Ingredients (API) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
      6. By Country
        1. Saudi Arabia
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        2. UAE
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        3. Qatar
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        4. Kuwait
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        5. South Africa
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        6. Nigeria
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        7. Algeria
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
        8. Rest of MEA
          1. By API
          2. By Manufacturer
          3. By Type of Drug
          4. By Therapeutic Area
          5. By Potency
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Active Pharmaceutical Ingredients (API) Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid–19 on India Worm Gear Reducers Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Teva Pharmaceutical Industries Ltd
    2. Pfizer Inc.
    3. Novartis International AG
    4. Mylan N.V.
    5. Aurobindo Pharma Ltd
    6. Sun Pharmaceutical Industries Ltd
    7. Boehringer Ingelheim GmbH
    8. Dr. Reddy's Laboratories Ltd
    9. Merck & Co., Inc.
    10. Lonza Group Ltd
    11. Bristol–Myers Squibb
    12. GlaxoSmithKline plc
    13. AbbVie Inc.
    14. Lupin Limited
    15. Cipla Ltd
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.    Qualitative Research
      1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of case of non–listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in–depth secondary research for the final deliverable

 

Figures

Figure 1       Global Active Pharmaceutical Ingredients (API) Market Segmentation                                                            

Figure 2       Global Active Pharmaceutical Ingredients (API) Market - Market Value Chain Analysis                                                               

Figure 3       Company Market Share Analysis, 2022                                                         

Figure 4       Global Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 5       Global Active Pharmaceutical Ingredients (API) Market - Market Share, By API, By Value, 2019−2029                                                         

Figure 6       Global Active Pharmaceutical Ingredients (API) Market - Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 7       Global Active Pharmaceutical Ingredients (API) Market - Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 8       Global Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 9       Global Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 11     Global Active Pharmaceutical Ingredients (API) Market, Market Share, By Region, By Value, 2019−2029                                                              

Figure 12     North America Active Pharmaceutical Ingredients (API) Market, Market Size, By Value (USD Billion), 2019−2029                                                         

Figure 13     North America Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                                 

Figure 14     North America Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 15     North America Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 16     North America Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 17     North America Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                         

Figure 19     North America Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029                                                          

Figure 20     United States Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 21     United States Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                                 

Figure 22     United States Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 23     United States Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 24     United States Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 25     United States Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                         

Figure 26     Canada Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 27     Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 28     Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 29     Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 30     Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 31     Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 32     Europe Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 33     Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 34     Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 35     Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 36     Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 37     Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 38     Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029                                                              

Figure 39     Germany Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 40     Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 41     Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 42     Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                           

Figure 43     Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 44     Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 45     United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                         

Figure 46     United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                                 

Figure 47     United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 48     United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 49     United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 50     United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                         

Figure 51     Italy Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 52     Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 53     Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 54     Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 55     Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                               

Figure 56     Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 57     France Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 58     France Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                          

Figure 59     France Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 60     France Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 61     France Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 62     France Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 63     Spain Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 64     Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 65     Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 66     Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 67     Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 68     Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 69     The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                         

Figure 70     The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                                 

Figure 71     The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 72     The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 73     The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 74     The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                         

Figure 75     Belgium Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 76     Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 77     Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 78     Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 79     Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 80     Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 81     Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 82     Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                                 

Figure 83     Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 84     Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 85     Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 86     Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                         

Figure 87     Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 88     Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 89     Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 90     Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                           

Figure 91     Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 92     Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 93     Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029                                                          

Figure 94     China Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 95     China Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 96     China Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 97     China Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 98     China Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 99     China Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 100   India Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 101   India Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 102   India Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 103   India Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 104   India Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 105   India Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 106   Japan Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 107   Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 108   Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 109   Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 110   Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 111   Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 112   South Korea Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 113   South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 114   South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 115   South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 116   South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 117   South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 118   Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                         

Figure 119   Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                           

Figure 120   Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                               

Figure 121   Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                                

Figure 122   Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                          

Figure 123   Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                            

Figure 124   Indonesia Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 125   Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 126   Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 127   Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                           

Figure 128   Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 129   Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 130   Malaysia Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 131   Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 132   Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 133   Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 134   Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 135   Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 136   Singapore Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 137   Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 138   Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 139   Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                           

Figure 140   Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 141   Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 142   Philippines Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 143   Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 144   Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 145   Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                           

Figure 146   Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 147   Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 148   Vietnam Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 149   Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 150   Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 151   Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 152   Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 153   Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 154   Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 155   Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                                 

Figure 156   Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 157   Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 158   Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 159   Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 160   Latin America Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 161   Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                                 

Figure 162   Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 163   Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 164   Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 165   Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                        

Figure 166   Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029                                                          

Figure 167   Brazil Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 168   Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 169   Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 170   Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 171   Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 172   Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 173   Mexico Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 174   Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 175   Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 176   Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 177   Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 178   Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 179   Argentina Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 180   Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 181   Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 182   Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                           

Figure 183   Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 184   Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 185   Peru Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 186   Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 187   Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 188   Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 189   Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                               

Figure 190   Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 191   Colombia Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 192   Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 193   Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 194   Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                           

Figure 195   Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 196   Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 197   Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 198   Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                                 

Figure 199   Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 200   Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 201   Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 202   Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                         

Figure 203   Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                         

Figure 204   Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                            

Figure 205   Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                                

Figure 206   Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                                 

Figure 207   Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                           

Figure 208   Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                             

Figure 209   Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029                                                               

Figure 210   Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 211   Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 212   Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 213   Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 214   Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 215   Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 216   UAE Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 217   UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 218   UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 219   UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 220   UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                               

Figure 221   UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 222   Qatar Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 223   Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 224   Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 225   Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 226   Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 227   Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 228   Kuwait Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 229   Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 230   Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 231   Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 232   Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 233   Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 234   Iran Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 235   Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 236   Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 237   Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 238   Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                               

Figure 239   Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 240   South Africa Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 241   South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 242   South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 243   South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                            

Figure 244   South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 245   South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 246   Nigeria Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 247   Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 248   Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 249   Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 250   Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 251   Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 252   Kenya Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 253   Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 254   Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 255   Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 256   Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 257   Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 258   Egypt Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 259   Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 260   Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 261   Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 262   Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 263   Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 264   Morocco Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 265   Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 266   Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 267   Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 268   Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 269   Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

Figure 270   Algeria Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                          

Figure 271   Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                         

Figure 272   Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 273   Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                              

Figure 274   Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 275   Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                              

Figure 276   Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029                                                                 

Figure 277   Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029                                                              

Figure 278   Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029                                                            

Figure 279   Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029                                                           

Figure 280   Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029                                                                

Figure 281   Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029                                                               

 

List of Tables

 

Table 1 Global Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 2 Global Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 3 Global Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 4 Global Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 5 Global Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 6 Global Active Pharmaceutical Ingredients (API) Market Size, By Region, By Value, 2019−2029

Table 7 North America Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 8 North America Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 9 North America Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 11      North America Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 12      North America 

Table 13      North America Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 14      United States Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 15      United States Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 16      United States Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 17      United States Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 19      Canada Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 20      Canada Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 21      Canada Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 22      Canada Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 23      Canada Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 24      Europe Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 25      Europe Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 26      Europe Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 27      Europe Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 28      Europe Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 29      Europe Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 30      Germany Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 31      Germany Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 32      Germany Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 33      Germany Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 34      Germany Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 35      United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 36      United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 37      United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 38      United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 39      United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 40      Italy Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 41      Italy Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 42      Italy Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 43      Italy Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 44      Italy Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 45      France Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 46      France Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 47      France Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 48      France Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 49      France Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 50      Spain Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 51      Spain Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 52      Spain Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 53      Spain Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 54      Spain Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 55      The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 56      The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 57      The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 58      The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 59      The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 60      Belgium Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 61      Belgium Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 62      Belgium Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 63      Belgium Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 64      Belgium Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 65      Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 66      Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 67      Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 68      Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 69      Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 70      Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 71      Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 72      Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 73      Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 74      Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 75      Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 76      China Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 77      China Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 78      China Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 79      China Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 80      China Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 81      India Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 82      India Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 83      India Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 84      India Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 85      India Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 86      Japan Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 87      Japan Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 88      Japan Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 89      Japan Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 90      Japan Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 91      South Korea Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 92      South Korea Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 93      South Korea Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 94      South Korea Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 95      South Korea Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 96      Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 97      Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 98      Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 99      Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 100    Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 101    Indonesia Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 102    Indonesia Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 103    Indonesia Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 104    Indonesia Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 105    Indonesia Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 106    Malaysia Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 107    Malaysia Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 108    Malaysia Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 109    Malaysia Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 110    Malaysia Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 111    Singapore Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 112    Singapore Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 113    Singapore Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 114    Singapore Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 115    Singapore Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 116    Philippines Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 117    Philippines Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 118    Philippines Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 119    Philippines Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 120    Philippines Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 121    Vietnam Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 122    Vietnam Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 123    Vietnam Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 124    Vietnam Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 125    Vietnam Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 126    Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 127    Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 128    Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 129    Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 130    Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 131    Latin America Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 132    Latin America Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 133    Latin America Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 134    Latin America Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 135    Latin America Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 136    Latin America Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 137    Brazil Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 138    Brazil Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 139    Brazil Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 140    Brazil Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 141    Brazil Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 142    Mexico Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 143    Mexico Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 144    Mexico Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 145    Mexico Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 146    Mexico Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2030

Table 147    Argentina Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 148    Argentina Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 149    Argentina Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 150    Argentina Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 151    Argentina Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 152    Peru Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 153    Peru Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 154    Peru Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 155    Peru Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 156    Peru Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 157    Colombia Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 158    Colombia Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 159    Colombia Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 160    Colombia Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 161    Colombia Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 162    Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 163    Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 164    Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 165    Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 166    Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 167    Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 168    Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 169    Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 170    Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 171    Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 172    Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 173    Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 174    Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 175    Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 176    Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 177    Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 178    UAE Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 179    UAE Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 180    UAE Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 181    UAE Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 182    UAE Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 183    Qatar Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 184    Qatar Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 185    Qatar Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 186    Qatar Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 187    Qatar Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 188    Kuwait Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 189    Kuwait Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 190    Kuwait Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 191    Kuwait Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 192    Kuwait Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 193    Iran Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 194    Iran Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 195    Iran Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 196    Iran Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 197    Iran Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 198    South Africa Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 199    South Africa Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 200    South Africa Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 201    South Africa Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 202    South Africa Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 203    Nigeria Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 204    Nigeria Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 205    Nigeria Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 206    Nigeria Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 207    Nigeria Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 208    Kenya Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 209    Kenya Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 210    Kenya Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 211    Kenya Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 212    Kenya Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 213    Egypt Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 214    Egypt Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 215    Egypt Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 216    Egypt Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 217    Egypt Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 218    Morocco Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 219    Morocco Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 220    Morocco Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 221    Morocco Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 222    Morocco Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 223    Algeria Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 224    Algeria Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 225    Algeria Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 226    Algeria Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 227    Algeria Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 228    Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 229    Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 230    Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 231    Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 232    Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 233    Teva Pharmaceutical Industries Ltd Company Overview

Table 234    Teva Pharmaceutical Industries Ltd Financial Overview

Table 235    Pfizer Inc. Company Overview

Table 236    Pfizer Inc. Financial Overview

Table 237    Novartis International AG Company Overview

Table 238    Novartis International AG Financial Overview

Table 239    Mylan N.V. Company Overview

Table 240    Mylan N.V. Financial Overview

Table 241    Aurobindo Pharma Ltd Company Overview

Table 242    Aurobindo Pharma Ltd Financial Overview

Table 243    Sun Pharmaceutical Industries Ltd Company Overview

Table 244    Sun Pharmaceutical Industries Ltd Financial Overview

Table 245    Boehringer Ingelheim GmbH Company Overview

Table 246    Boehringer Ingelheim GmbH Financial Overview

Table 247    Dr. Reddy's Laboratories Ltd Company Overview

Table 248    Dr. Reddy's Laboratories Ltd Financial Overview

Table 249    Merck & Co., Inc. Company Overview

Table 250    Merck & Co., Inc. Financial Overview

Table 251    Lonza Group Ltd Company Overview

Table 252    Lonza Group Ltd Financial Overview

Table 253    Bristol-Myers Squibb Company Overview

Table 254    Bristol-Myers Squibb Financial Overview

Table 255    Cipla Ltd Company Overview

Table 256    Cipla Ltd Financial Overview

Table 257    Other Prominent Players Company Overview

Table 258    Other Prominent Players Financial Overview